Singapore Pharmaceutical Market Outlook 2017-2030 – by Goldstein Market Intelligence

, In 2016, Singapore government invested around USD 13 billion in the development of healthcare facilities in the region.

NEW YORK, NY, UNITED STATES OF AMERICA, March 31, 2020 /EINPresswire.com/ — Singapore Pharmaceutical Market Outlook 2017-2030 – by Goldstein Market Intelligence

According to the Goldstein Market Intelligence forecast, In 2016, Singapore government invested around USD 13 billion in the development of healthcare facilities in the region. As per Ministry of Singapore Health, there were 12,000 hospital beds in 25 hospitals and specialty centers in Singapore.
A more recent investment of $1 billion to develop several research institutes and the Biopolis R&D complex. Together, the investments have attracted more than 30 major global life-sciences companies and created an effective ecosystem that harnesses the benefits of economies of scale and knowledge transfer. The first tier of protection comprises government subsidies of up to 80 percent of the total cost of care provided in public hospitals and primary care polyclinics. This is supported by a group of savings and insurance programs known as the “3Ms” system—for Medisave, MediShield, and Medifund—which plays a critical role in maintaining the public’s health and welfare.

Report is available at :- https://bit.ly/2Uv4YIp
Market dynamic / Drivers & Restraints to Market Growth
Increase in aging population and focusing on fitness & healthy lifestyle is predicted to rise the Singapore pharmaceuticals market. Rise in aging population in many nations across the globe is a major a growth driver for the pharmaceutical industry. Occupational stress across diverse work settings including job insecurity, work hours, job quality (job strain, job control) and wages.
Meanwhile, the innovative pharmaceutical industry is currently facing unprecedented challenges caused by slower sales growth, expiring patents, increasing competition from generics, shorter product life cycles, tighter regulations, adverse media coverage and reputational damage, and a decline in the number of new innovative drugs under development.

Request for Sample Report at :- https://bit.ly/2WSoHDI

Covered in this Singapore Pharmaceutical Market Outlook 2030 Report are
“Singapore Pharmaceutical Market Outlook 2030” by Goldstein Research contains detailed overview of Singapore Pharmaceutical Market in terms of market segmentation by analysis basis, therapy type and geography. The Report highlights the competitive outlook of major global players that includes the business strategies, product portfolio, revenue distribution, financial analysis, R&D activities, and investments. The in-depth analysis of POS Terminal Market report will help the clients to assess their business strategies as per the competitive environment in the market space.

Major players covered in this POS Terminal Market report are:
• GlaxoSmithKline (GSK)
• Abbot Laboratories
• Lonza
• Merck Sharp & Dohme
• Takeda
• Roche Holding AG
• Pfizer Inc.
• Raffles Medical Group Ltd.
• Wave Life Sciences
• Sphaera Pharma
• Special Access Pharma
• Pharmaskin
• NCI Health
• Melbourne Drugs

Further, Singapore Pharmaceutical Market Report encompasses the major trends & opportunities, market dynamics and other growth factors of the market Singapore Pharmaceutical Market outlook also comprises of key challenges, risk analysis, BPS analysis, SWOT Analysis and Market Attractiveness. The report also highlights the expert analysis to provide a complete overview of the market including the PESTLE analysis of each region and country.
About Goldstein Research
Based in the US, Goldstein Research currently has a strong presence in the American and Asian countries. In the next five years, we strive to expand our reach to 50+ nations spanning across Europe, Asia and parts of the Middle East and Africa. We strive to realize a strong brand presence globally through our quality research and forecasting solutions.
Our mission is simple: to develop insightful business solutions, help our clients make powerful future decisions to keep them well ahead of the game which is the market, and leave a mark across businesses and communities through our well-defined ideas and clear-cut forecasts. Our market research reports provide in-depth analysis of global and regional variations along with competitors’ overview.
Our analysts working on chemicals construction to help various tech-giants, tech start-ups and entry players to assess the current and upcoming business scenario. We believe in the vigorous examination of the current market scenario and build around creative ideas and approaches that are most suitable to our clients’ needs and business agenda.

Contact for more Info:

Dennis Abraham
(Global Sales Head)

UK:
+44 7520 644482
dennis.abraham@goldsteinresearch.com
www.goldsteinresearch.com

Steve Blades
Goldstein Research
+1 646-568-7747
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

Mental Health Watchdog Keeps Service Open for Consumers to Report Abuse & Fraud

With $1.7 billion allocated to mental health programs in response to COVID-19 fears and concerns, CCHR anticipates increase in telepsychiatry fraud and abuse. It offers tips for consumers on detecting online scams and avoiding psychotropic drug risks.

With $1.7 billion allocated to mental health programs in response to COVID-19 fears and concerns, CCHR anticipates increase in telepsychiatry fraud and abuse. It offers tips for consumers on detecting online scams and avoiding psychotropic drug risks.

With $1.7 billion allocated to mental health programs in response to COVID-19 fears and concerns, CCHR anticipates increase in telepsychiatry fraud and abuse.

CCHR urges people to use its service and report abuse and to access its psychiatric drugs side effects database to become better informed about these drugs risks.”

— CCHR International

LOS ANGELES, CALIFORNIA, UNITED STATES, March 31, 2020 /EINPresswire.com/ — Staff at Citizens Commission on Human Rights International, while operating remotely from their homes during the Coronavirus pandemic, is still servicing patients that are experiencing, and need to report, abuse in the mental health system. CCHR is increasing its oversight of the industry in light of the recent federal stimulus package that has allocated $425 million for mental health services and an additional $1.32 billion for community mental health centers (CMHCs).[1]

CCHR is very mindful of the fears and uncertainties that many are facing with the COVID-19 crisis and the need to communicate those concerns with someone. However, it says that, in what it thinks is an altruistic, but misguided action, the Federal government has loosened the regulations surrounding “telepsychiatry” (also known as digital psychiatry) to access psychiatric treatment via the Internet. While psychiatrists and psychologists were limited to practicing telepsychiatry in rural areas in their own state, a special waiver will now allow them to treat across the entire nation.[2] A psychiatrist could hold a group therapy session with patients in five different states.[3]

“It is wide open to abuse,” Jan Eastgate, President of CCHR says. A recent American Psychiatric Association survey of 1,004 Americans deduced that over 40% of the nation is anxious about dying or becoming seriously ill from COVID-19, which CCHR says could send consumers thinking they need online “telepsychiatry” services, running the risk of being prescribed mind-altering drugs.

One incentive is that psychiatrists would get paid the same rate as they do for seeing a patient in person. Telepsychiatry averages $68 and $107, whereas an in-person consultation can be up to $500.

Another waiver allows them to prescribe controlled substances (highly addictive psychotropic drugs) via the Internet. The drugs come with serious risks and side effects.[4]

This makes oversight of telepsychiatry fraud and prescription abuse difficult. In a national survey of 48 state medical boards the most common physician violations online were inappropriate patient communication online, e.g., sexual misconduct, and prescribing without an established clinical relationship.[5]

The psychiatric invented disorder, “health-” or “illness anxiety” is already seeping into COVID-19 nomenclature, described as an irrational and obsessive worry with having a serious medical condition. It is allegedly marked by a person’s imagination of physical symptoms of illness. Like all mental disorders listed in the Diagnostic and Statistical Manual for Mental Disorders (DSM-5), experts do not know the exact causes, according to Johns Hopkins School of Medicine.[6]

Psychiatrist Alan Frances, former head of the DSM-IV Task Force wrote, “Adding to the woes of the medically ill could be one of the biggest problems caused by DSM5. It will do this in two ways: 1) by encouraging a quick jump to the erroneous conclusion that someone’s physical symptoms are ‘all in the head’; and 2) by mislabeling as mental disorders what are really just the normal emotional reactions that people understandably have in response to a medical illness.”[7]

Eastgate says that while CCHR supports the need for more funded healthcare, in the mental health field, this could be a recipe for greed and fraud. The Justice Department has already needed to crack down on telehealth fraud.[8] Last year, five telemedicine companies were criminally charged over fraud schemes involving more than $1.2 billion in losses.[9]

Medical Guardian advises on how to spot a telemedicine scam.

1. They ONLY suggest talking to you virtually.

2. They reassure you that your health insurance will cover the payments.

3. A big red flag for Medicare fraud is any type of physician who will write you a prescription for pharmaceuticals without meeting with you in person first.[10] While meeting in person is waived under new regulations because of COVID-19, CCHR says to be alert to multiple “psychotropic drug prescriptions” as a potential sign of fraud.

Investment into mental health technology has already boomed, reaching $769 million in 2019. Research shows an almost five-fold increase in mental health tech investment in the last six years, rising from $200.9 million in 2014.[11]

The American Medical Association (AMA) reports that according to one study, younger children are good prospects for telepsychiatry as they appear to be less inhibited when using it and those with significant behavior and conduct problems may be more “expressive” in that venue.[12] CCHR says America has more than 6.7 million children and adolescents already taking psychotropic drugs,[13] which telepsychiatry will only add to. UK health advocate, Suzy Chapman, who closely monitored every step in the development of DSM-5, wrote about health anxiety: “These are inherently unreliable and untrustworthy judgments that will open the floodgates to the overdiagnosis of mental disorder and promote the missed diagnosis of medical disorder.”[14]

CCHR urges people to use its service and report abuse and to access its psychiatric drugs side effects database to become better informed about these drugs risks, especially when taken during a time we need to remain alert.

CCHR is the mental health watchdog responsible for more than 180 laws that now protect patients from damaging practices. DONATE to support its work here: https://www.cchrint.org/cchrint-donate/

References:

[1] “APA Praises Mental Health Provisions in COVID-19 Stimulus Aid Package,” APA release, 27 Mar. 2020,
https://www.psychiatry.org/newsroom/news-releases/apa-praises-mental-health-provisions-in-covid-19-stimulus-aid-package
[2] “COVID-19: Dramatic Changes to Telepsychiatry Rules and Regs,” Medscape, 26 Mar. 2020, https://www.medscape.com/viewarticle/927556
[3] Daphne C. Ferrer, MD and Peter M. Yellowlees, MBBS, MD, “Telepsychiatry: Licensing and Professional Boundary Concerns,” AMA Journal of Ethics, Jun 2012, https://journalofethics.ama-assn.org/article/telepsychiatry-licensing-and-professional-boundary-concerns/2012-06
[4] “Understanding hypochondria in this time of Covid-19,” CDN, 24 Mar. 2020, https://cebudailynews.inquirer.net/296714/understanding-hypochondria-in-this-time-of-covid-19#ixzz6HdmWZBGV
[5] Op. cit., AMA Journal of Ethics, https://journalofethics.ama-assn.org/article/telepsychiatry-licensing-and-professional-boundary-concerns/2012-06
[6] “Understanding hypochondria in this time of Covid-19,” CDN, 24 Mar. 2020, https://cebudailynews.inquirer.net/296714/understanding-hypochondria-in-this-time-of-covid-19#ixzz6HdmWZBGV
[7] Allen Frances, M.D., “Mislabeling Medical Illness As Mental Disorder: The eleventh DSM 5 mistake needs an eleventh hour correction,” Psychology Today, 12 Dec. 2020, https://www.psychologytoday.com/us/blog/dsm5-in-distress/201212/mislabeling-medical-illness-mental-disorder
[8] https://mhealthintelligence.com/news/telehealth-in-the-spotlight-as-justice-cracks-down-on-medicare-fraud
[9] https://www.jdsupra.com/legalnews/telehealth-two-steps-forward-for-22452/
[10] https://www.medicalguardian.com/medical-alert-blog/current-events/the-difference-between-real-telemedicine-services-vs-scams
[11] “Global investment in mental health technology surges above half a billion pounds,” Mobile Health News, 3 Feb. 2020, https://www.mobihealthnews.com/news/europe/global-investment-mental-health-technology-surges-above-half-billion-pounds
[12] Op. cit., AMA Journal of Ethics, https://journalofethics.ama-assn.org/article/telepsychiatry-licensing-and-professional-boundary-concerns/2012-06
[13] https://www.fightforkids.org/
[14] Op. cit., Psychology Today, https://www.psychologytoday.com/us/blog/dsm5-in-distress/201212/mislabeling-medical-illness-mental-disorder

Amber Rauscher
Citizens Commission on Human Rights
+1 323-467-4242
email us here
Visit us on social media:
Facebook
Twitter


Source: EIN Presswire

Affordable Dental Solutions in Reading Remains Open During COVID-19 for Emergency Care

logo for Affordable Dental Solutions

Affordable Dental Solutions remains open to offer emergency dental care in Reading

ADS is offering emergency dental care and has enhanced its strong safety measures.

READING, PENNSYLVANIA, UNITED STATES, March 31, 2020 /EINPresswire.com/ — Affordable Dental Solutions in Reading is remaining open during COVID-19, offering emergency dental care to patients in Berks County.

“We have enhanced our safety measures and are ensuring that we meet the latest ADA and CDC safety precautions,” says Dr. Catherine Alger, dentist in Reading.

These measures include disinfecting treatment areas and tools between each patient. Patients will also be bypassing waiting rooms and common areas so that they can be seen securely in their sanitized treatment room. All high-touch areas are being sanitized regularly, including doorknobs and restroom surfaces.

Dental emergencies include severe tooth pain, dental trauma, tooth fractures, and uncontrolled bleeding. By accepting patients with dental emergencies, ADS hopes to alleviate the burden placed on local hospitals and their emergency departments.

Patients in severe tooth pain are urged to request an appointment with ADS in Reading by calling (610) 401-0567. ADS offices in Easton and Limerick also remain open.

About Affordable Dental Solutions: Based in Eastern Pennsylvania, Affordable Dental Solutions is a provider of full dentistry services. For nearly a decade, Affordable Dental Solutions has offered patients procedures such as dental implants, crowns, and dentures at rates much lower than area competitors by utilizing state-of-the-art equipment and by negotiating discounts with implant manufacturing companies. Learn more at https://www.affordabledentalsolutions.com/.

Jamie Smith
Affordable Dental Solutions
(484) 948-2900
email us here
Visit us on social media:
Facebook

About Affordable Dental Solutions


Source: EIN Presswire

Reprocessed Medical Device Market Outlook 2017-2030 – by Goldstein Market Intelligence

“One trend is partnering with the vendor in order to understand and buy the reprocess medical devices.

NEW YORK, NY, UNITED STATES OF AMERICA, March 31, 2020 /EINPresswire.com/ — Reprocessed Medical Device Market Outlook 2017-2030 – by Goldstein Market Intelligence

According to the Goldstein Market Intelligence forecast, “One trend is partnering with the vendor in order to understand and buy the reprocess medical devices. While the vendor community is divided about the benefits of reprocessing devices, many product vendors and consultancies offer services to assist hospitals in reprocessing and reusing devices.”

Recent studies on medical devices market suggest that until a decade back, medical device reprocessing was mostly performed by hospital staffs within a hospital setting, and without any proper regulations and guidelines. However, with the introduction of FDA reprocessing guidelines, medical device reprocessing is being adopted gradually across the globe. Hence, at present, most hospitals and healthcare facilities outsource medical device reprocessing to qualified third party service providers. . Encouraging regulatory policies and the increased use of reprocessed medical devices across the healthcare sector are likely to seal North America’s dominance in the global frontier through the forecast period. Moreover, reduced pricing and improved quality of reprocessed medical devices are some of the additional factors driving the growth of the market.
Report is available at:- https://bit.ly/33XcK17
Market dynamic / Drivers & Restraints to Market Growth
 The trend toward sustainability and lowering VOCs continues to pick up steam in the Reprocessed Medical Device market. "VOC and related regulations continue to be implemented and expanded dictating manufacturers to formulate new and more environmentally friendly products. Cost effectiveness and innovation in Reprocessed Medical Devices are propelling the market growth of Reprocessed Medical Device and is expected to impact the growth positively. However , the major restraining factors of the global air purifiers market are placing of air purification systems as luxury goods and high pricing of products restricting in consumption. Moreover, the major opportunities for the global air purifiers market is upsurge in disposable income globally.

Request for Sample Report at:- https://bit.ly/2JuJ6GQ
Covered in this POS Terminal Market Report are
“POS Terminal Market Outlook 2030” by Goldstein Research contains detailed overview of POS Terminal Market in terms of market segmentation by analysis basis, therapy type and geography. The Report highlights the competitive outlook of major global players that includes the business strategies, product portfolio, revenue distribution, financial analysis, R&D activities, and investments. The in-depth analysis of POS Terminal Market report will help the clients to assess their business strategies as per the competitive environment in the market space.

Major players covered in this POS Terminal Market report are:
Centurion Medical Products Corporation
Hygia Health Services Inc.
Medline ReNewal
MidWest Reprocessing Center
ReNu Medical Inc.
Ethicon Inc. (Johnson & Johnson)
Stryker Sustainability Solutions Inc.
SureTek Medical
Vanguard AG.

Further, POS Terminal Market Report encompasses the major trends & opportunities, market dynamics and other growth factors of the market. POS Terminal Market outlook also comprises of key challenges, risk analysis, BPS analysis, SWOT Analysis and Market Attractiveness. The report also highlights the expert analysis to provide a complete overview of the market including the PESTLE analysis of each region and country.
About Goldstein Research
Based in the US, Goldstein Research currently has a strong presence in the American and Asian countries. In the next five years, we strive to expand our reach to 50+ nations spanning across Europe, Asia and parts of the Middle East and Africa. We strive to realize a strong brand presence globally through our quality research and forecasting solutions.
Our mission is simple: to develop insightful business solutions, help our clients make powerful future decisions to keep them well ahead of the game which is the market, and leave a mark across businesses and communities through our well-defined ideas and clear-cut forecasts. Our market research reports provide in-depth analysis of global and regional variations along with competitors’ overview.
Our analysts working on chemicals construction to help various tech-giants, tech start-ups and entry players to assess the current and upcoming business scenario. We believe in the vigorous examination of the current market scenario and build around creative ideas and approaches that are most suitable to our clients’ needs and business agenda.

Contact for more Info:

Dennis Abraham
(Global Sales Head)
UK:
+44 7520 644482
dennis.abraham@goldsteinresearch.com
www.goldsteinresearch.com

Steve Blades
Goldstein Research
+1 646-568-7747
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

ExAM4Inspections providing standardized Infectious Disease Control software to hospitals

ExAM4Inspections.com Logo

ExAM4Inspections.com

MBA Logo

MBA Logo

MB&A providing its ExAM4Inspections.com solution supporting infectious disease control and healthcare associated infection solutions to the healthcare market.

Our IDC and HAI accelerators will enable our customers to get programs started faster than ever before which is especially important right now as we work to stop the spread of COVID-19.”

— Bradley Hilker, Strategic Account Executive

ARLINGTON, VIRGINIA, UNITED STATES, March 31, 2020 /EINPresswire.com/ — Millsapps, Ballinger & Associates, LLC (MB&A) announced that they are delivering standardized rollout and delivery of the companies ExAM4Inspections.com Salesforce AppExchange product (ExAM) in support of Infectious Disease Control (IDC) and Healthcare Associated Infections (HAI). The approach has been used at more than a dozen hospitals to date and promises a standardized and rapid on boarding that helps hospitals respond to the need to control infectious diseases.

The standardization of key programs ExAM supports such as Hand Hygiene (HH), Sterile Processing, Operating Room Inspections and Patient Care Area Quality Assurance Inspections form a critical component of a hospital’s front line in the fight against infection. With the rise of COVID-19 (Coronavirus), programs like these help hospitals understand and employ best practices with regard to ensuring basic patient and caregiver safety.

Even before the onset of COVID-19, healthcare leadership has been pushing tirelessly for funding to support Infection Prevention and Control (IPC) programs to assure their facilities are taking the necessary steps to combat the spread of viruses and other infectious diseases. As an example one of our customers at Martinsburg VA Medical Center estimates in an internal cost benefit analysis the implementation of ExAM4Inspections would enable them to “reallocate 536 hours of IPC time currently spent performing administrative tasks to more specialized Infection Prevention and Control duties. Although the value of IPC time can be challenging to precisely quantify, reallocation towards additional prevention, training and education is worthwhile considering a single S. aureus bloodstream infection recently cost facilities more than $100,000.” This was of course written prior to the COVID-19 pandemic, but it hints at the scale of the cost reduction in human lives and dollars that could be achieved by leveraging the Salesforce AppExchange product ‘ExAM4Inspections’ to confirm proper standards are met, and to enable leadership to make necessary decisions and adjustments in real time.

MB&A has been awarded the CIO Applications Top 25 Salesforce Solution Providers of 2019. MB&A was recognized for their groundbreaking Salesforce AppExchange product ExAM (ExAM4Inspections.com) which is currently being used to enable adherence to standards at hospitals nationwide.

Learn More at ExAM4Inspections.com

Bradley Hilker
MB&A
+1 703-973-5404
email us here


Source: EIN Presswire

Coming Together to Support Businesses and Employees

Free Resource Kit for Businesses & Non-Profits from vitalink

Free Resource Kit for Businesses & Non-Profits from vitalink

North Carolina agency offers toolkit to help during these challenging times

RALEIGH, NORTH CAROLINA, USA, March 31, 2020 /EINPresswire.com/ — vitalink, a purpose-driven marketing and branding firm, is providing a free downloadable toolkit with support tools to help businesses, non-profits, and employees through the current health crisis and these challenging times. Tools can be found at www.vitalinkweb.com/free-biz-kit and include:
• Business resources
• Tech and cybersecurity tips
• Tips for working remotely
• Press-ready artwork to customize with your logo
• Communication tips and materials
• Things to do at home to keep everyone engaged and learning
• Links to health news and updates

In addition, vitalink is offering a free webinar titled, Proactive Communications for a New Era. The virtual session will take place on April 16 at 12:45 p.m. Eastern time and will allow attendees to learn and ask questions about how to best position their marketing and branding as we begin to work to recover from the challenges we’ve been handed. The first 10 people to register for the webinar (at https://www.vitalinkweb.com/free-biz-kit) will receive a 20-minute strategy session with vitalink president, Jeanne Frazer. While the strategy session is free, vitalink encourages participants to make a donation to the charity of their choice.

“As a small business owner, I see and feel the economic and social ripples this virus is having across North Carolina, the United States, and the world,” says Jeanne Frazer, president of vitalink. “Many companies are struggling to retain employees. Those that can have employees work remotely are struggling to manage a remote workforce and learn new technologies. Employees are re-ordering their lives to deal with getting their work done while the kids are home. We have pulled together tools, best practices and other resources to help business owners and their employees. Being purpose-driven is at the core of who we are, and we own our purpose-driven focus by giving back to our communities. This tool kit is one way we can help everyone deal with the immediate challenges and those we will all face as we rebuild our businesses.”

About vitalink
vitalink (www.vitalinkweb.com) is a purpose-driven branding and marketing firm. vitalink partners with clients to build purposeful, prosperous brands that speak to their communities.

We are a small, woman-owned business founded in 1996. vitalink has a strong commitment to education and has presented numerous learning sessions for businesses and non-profits. vitalink is a founding partner of HBCUgrow (www.hbcugrow.com). Empowering purpose fuels results.

-###-

Kathy Horn
vitalink
+1 704-773-0283
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

Tampa Bay Medical Clinic Investigates Potential of VITAMIN C as Coronavirus Treatment

DOCS Outside the Box! announced today that it is investigating the use of many options to treat suspected or confirmed cases of CoVid-19.

We are investigating all the options that are available and keeping our patients informed of their options”

— Leah Teekell-Taylor, M.D., Medical Director of Docs Outside the Box!

ST PETERSBURG, FLORIDA, UNITED STATES, March 31, 2020 /EINPresswire.com/ — DOCS Outside the Box! announced today that it is investigating the use of many options to treat suspected or confirmed cases of CoVid-19. These options include combination of Azithromycin and Hydroxychloroquine, intravenous vitamin C, Traditional Chinese herbals and other whole food-based supplements.

Although there have been several positive reports for the use of VITIMIN C, there have also been reports that vitamin C may not protect an individual from infection. DOCS Outside the Box! prides itself on empowering its patients and providing all potential options that are available for medical care. In addition to VITIMIN C, DOCS Outside the Box! is also educating its patients about other supplements that can help to strengthen and build stronger immune systems.

Docs Outside the Box! has implemented multiple protocols since the identification of COVID-19 as a growing pandemic. This includes the creation of a second entrance for individuals suspected of infection, the requirement that patients wait in cars prior to being escorted in for treatment, the sanitization of treatment rooms after each encounter, and the requirement that staff wear personal protective equipment.

Docs! continues to see established patients but is willing to evaluate new patients who are acutely ill during this pandemic.

“Physicians in China and New York are reporting that patients who received VITIMIN C did significantly better than those who did not," said Leah Teekell-Taylor, M.D., Medical Director of Docs Outside the Box! "We are investigating all the options that are available and keeping our patients informed of their options.”

About DOCS Outside the Box!
Docs Outside the Box! is a holistic care clinic founded upon the principles of patient empowerment, continued wellness and transformative care. Our approach to care is a unique blend of Traditional and Holistic Medicine with a sole focus on the longevity of care and wellness across the whole patient. Our three-pronged care plans are comprehensive, educational and collaborative. Our goal is to ensure each patient is empowered along their care journey to take ownership of their life. We provide guidance to address physical, emotional and spiritual challenges, learn how to utilize their body to its greatest potential, understand all treatment options, including traditional and holistic means to care, take an active approach in making health changes, and learn to make the best health care choices for mind, body and soul; both in our office and in their daily lives.

Doug Pace
DOCS Outside the Box!
+1 7276416145
email us here


Source: EIN Presswire

Electronic Bone Growth Stimulators (BGS) Market By Type, By Application Type And Region-Global Forecast To 2027

Electronic Bone Growth Stimulators (BGS) Market

Electronic Bone Growth Stimulators (BGS) Market

Reports and Data

Reports and Data

Electronic Bone Growth Stimulators business scenario presented through self-explanatory charts, tables, and graphics images add greater value to the study.

NEW YORK, NY, UNITED STATES, March 31, 2020 /EINPresswire.com/ — Electronic Bone Growth Stimulators (BGS) Market By Type, By Application Type And Region-Global Forecast To 2027
The study includes an overall analysis of the Global Electronic Bone Growth Stimulators (BGS) Market and the study of its market trends to forecast the output for the coming years from 2020-2027. For the study, 2017 and 2018 are the historical years, and 2019 is the base year. This study will help give the reader an extensive idea about the market size, share, trends, and growth opportunities of this particular industry in the current and upcoming years.

Electronic Bone Growth Stimulators (BGS) Market: Introduction
Bone Growth Stimulator (BGS) is an electrical device that is used for the healing process of a fracture. BGS improves this process by the production of new cells by the use of the proper amount of electrical energy to the bone. This allows the fracture to heal faster. Stimulators are mainly used for hard-to-heal fractures. The bone growth stimulating results in an enhanced osteogenic environment with mineralization and calcification of the fibro-cartilage helps repair and heal the fracture site and increases the vascularity.

Click to get a SAMPLE PDF (Including Full TOC, Table & Figures) @ https://www.reportsanddata.com/sample-enquiry-form/2821

Electronic Bone Growth Stimulators (BGS) Market: Dynamics
In 2019, the market size of Electronic Bone Growth Stimulators was USD XX million and it was forecasted to reach USD XX million in 2027, growing at a stable CAGR of XX%.
With a slowdown in world economic growth, the Electronic Bone Growth Stimulators (BGS) industry has also been significantly affected but has still maintained an optimistic growth rate. The increase in obesity and the growth in the number of orthopedic injuries are the key driving forces boosting the Electronic Bone Growth Stimulator Market. The surging demand for innovative, safe, and modern treatment methods can also propel market growth.
Some of the key challenges that might hinder market growth are insufficient knowledge about the success rates of BGS and the higher treatment cost.

Electronic Bone Growth Stimulators (BGS) Market: Regional Outlook
The countries covered in the North American region include the U.S., Canada, and Mexico, while Asia-Pacific includes countries like China, India, Japan, Malaysia, South Korea, among others. Moreover, countries like Germany, France, the U.K., Spain, and the rest of Europe are included in the European region.
The U.S. drives the growth in the North American region as it is the largest market. The Asia-Pacific region also showed substantial potential for the market growth in the forecast period due to fast growth in markets such as India and China. The APAC region is expected to witness significant growth at a CAGR of XX% over the forecast period.

Electronic Bone Growth Stimulators (BGS) Market: Competitive Landscape
The Kidney Stone Retrieval Device Market comprises of several large and small scale players. Collaborations, agreements, product launches, mergers & acquisitions, partnerships are vital strategies being undertaken by the key market players to gain a competitive advantage in the industry. The market is also fragmented with many smaller vendors who are trying to improve and innovate the technology on their product line to increase their market share.

Buy your Exclusive copy Now @ https://www.reportsanddata.com/checkout-form/2821

The key players in the market include:
• Zimmer Biomet
• Ossatec
• Exogen
• Bioventus
• Orthofix International
• Djo Global
• Medtronic

Key coverage of the report
• This report provides and qualitative and quantitative analysis of the Electronic Bone Growth Stimulators (BGS) Market and detailed analysis of market share, size, and growth rate for all possible segments existing in the market. A growing trend is observed and predicted in the penetration of the industry over the years.
• Region and country-wise assessment for the forecast period, i.e., 2017-2027. In the study, 2017-2018 has been utilized as historical data, 2019 as the base year, and 2020-2027 as the forecast period.
• Market share analysis of the prominent industry players.
• Market forecasts of all the mentioned segments, and the regional markets.
• Key Market Trends (Drivers, Constraints, Threats, Opportunities, Challenges, recommendations).
• Strategic recommendations in important business segments based on the market estimations.
• Competitive landscaping and mapping the common key trends in the market.

Electronic Bone Growth Stimulators (BGS) Market: Segmentation
By Type (Revenue, USD Million; Volume in Tons, 2017–2027)
• Bone Growth Stimulation Devices
• Bone Morphogenetic Proteins (BMP)
• Platelet-Rich Plasma (PRP)

By Application Type (Revenue, USD Million; Volume in Tons, 2017–2027)
• Neurological Surgeries
• Oral Surgeries
• Non-unison Fractures

By Region (Revenue, USD Million; Volume in Tons, 2017–2027)
• North America
• Europe
• Latin America
• Middle East
• Africa
• Asia-Pacific

Electronic Bone Growth Stimulators (BGS) Market: Market Participants
• Zimmer Biomet
• Ossatec
• Exogen
• Bioventus
• Orthofix International
• Djo Global
• Medtronic

Browse the Complete Report Description and Full TOC@ https://www.reportsanddata.com/report-detail/electronic-bone-growth-stimulators-bgs-market

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Us:

John Watson
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com

John Watson
Reports and Data
+ +1 800-819-3052
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

Cocoa Powder Market To Reach USD 3.06 Billion By 2027

Cocoa Powder Market

Cocoa Powder Market

Reports and Data

Reports and Data

Cocoa Powder Market Size – USD 2.47 billion in 2018, Cocoa Powder Market Growth – CAGR of 2.3%

NEW YORK, NY, UNITED STATES, March 31, 2020 /EINPresswire.com/ — The global cocoa powder market is expected to reach USD 3.06 Billion by 2027, according to a new report by Reports and Data. The growth of the market is attributed to the growing application of cocoa powder.

Cocoa powder finds application in chocolate & confectionery products as a flavoring agent and a colorant. In confectionery, cocoa powder is utilized in large quantities as compared to other flavor ingredients and as a result of its chemical composition, cocoa powder has a high impact on the nutritional values, as well as the shelf life of the products. Besides, the negative zeta-potential and small size of the particles of cocoa powder are accountable for having a strong influence on the texture of certain food products.

The consumption of cocoa is advantageous for the functioning of platelets and blood vessels and in maintaining blood pressure. A cocoa beverage is found to reverse the endothelial dysfunction observed in hypertension, hyperlipidemia, and coronary artery disease. Cocoa is beneficial in augmenting the local levels of L-arginine necessary for the synthesis of Nitric oxide (NO) by endothelial NO synthase. Nitric oxide from endothelium helps in the relaxation of vascular muscle cells as well as prevents platelet adhesion and aggregation and leukocyte adhesion and migration, among others.

Click to get a SAMPLE PDF (Including Full TOC, Table & Figures) @ https://www.reportsanddata.com/sample-enquiry-form/2691

In the cosmetic industry, one of the uses of cocoa powder is in the soap making process, where it is used to give the soap a pleasant natural brown color. Commonly used products that may comprise cocoa powder are lip balm, face masks, bath bombs, shampoos & conditioners, scrubs, lotions, ointments, massage oils, creams, and facial toners.

Further key findings from the report suggest

• Dutch-processed cocoa powder finds application in homemade ice cream, chocolate desserts, and hot chocolate recipes. Unsweetened cocoa on being treated with an alkali, for neutralizing the acidic effect, forms Dutch-processed cocoa powder.
• By distribution channel, the offline distribution channel contributed to a larger market share in 2018 and is likely to observe a growth rate of 1.5% in the forecast period. Offline channel is the most preferred channel for distribution as it includes the opportunity for customers to create personal connections with business, which is beneficial in building loyalty.
• By application, cosmetics is projected to witness the fastest growth rate of 3.3% in the forecast period. Cocoa powder provides various skincare benefits, such as promoting the health of skin tissues, and firm and renew new skin cells, among others. Moreover, it functions as an antioxidant and aids in repairing damaged skin, enhances blood flow to the skin, and absorption of UV light into the skin.
• The market in the Asia Pacific region is anticipated to experience the fastest growth rate of 3.5% in the period 2019-2026. The high growth rate of the APAC region may be attributed to the growing demand for cocoa powder from the food & beverage industry. Further, changing food habits of the people in the region is causative of the growth of the market.
• Key participants include Cargill Incorporated, Nestle, Barry Callebaut, Jindal Cocoa, Carlyle Cocoa, Ghirardelli, Mars Incorporated, Puratos Group, Swiss Chalet Fine Products, and Cocoa Processing Company, among others.

Buy your Exclusive copy Now @ https://www.reportsanddata.com/checkout-form/2691

For the purpose of this report, Reports and Data have segmented the global cocoa powder market on the basis of type, distribution channel, application, and region:

Type Outlook (Volume, Kilo Tons; 2016-2027 and Revenue, USD Million; 2016-2027)
• Natural Cocoa Powder
• Dutch Process Cocoa Powder
• Others

Distribution Channel Outlook (Volume, Kilo Tons; 2016-2027 and Revenue, USD Million; 2016-2027)
• Online
• Offline

Application Outlook (Volume, Kilo Tons; 2016-2027 and Revenue, USD Million; 2016-2027)
• Chocolate & Confectionery
• Bakery
• Beverage
• Functional Food
• Pharmaceutical
• Cosmetics

Regional Outlook (Volume, Kilo Tons; 2016-2027 and Revenue, USD Million; 2016-2027)
• North America
o U.S
• Europe
o U.K
o France
• Asia Pacific
o China
o India
o Japan
• Latin America
o Brazil
• MEA

Browse the Complete Report Description and Full TOC@ https://www.reportsanddata.com/report-detail/cocoa-powder-market

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Us:

John Watson
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com

John Watson
Reports and Data
+ +1 800-819-3052
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

Dr. Rod Rohrich Honored Among the Top Plastic Surgeons in 2020 by Peers in Castle Connolly's Top Doctors Program

Dallas plastic surgeon, Dr. Rod J. Rohrich, has been recognized as one of the best plastic surgeons in the country by Castle Connolly's Top Doctors Program

DALLAS, TEXAS, UNITED STATES, March 31, 2020 /EINPresswire.com/ — Dallas plastic surgeon, Dr. Rod J. Rohrich, has been honored by peers as one of the best plastic surgeons in the country by Castle Connolly's Top Doctor's program. Every year, the program, which is designed to help patients find the best healthcare professionals in established medical specialties such as plastic surgery, carefully screens and selects physicians through a rigorous peer-review process.

During the nomination process, Castle Connolly contacts more than 50,000 licensed healthcare professionals nationwide to obtain nominations and feedback about the best doctors practicing in the United States today. They are asked to identify and nominate the most outstanding doctors in their medical specialty which they consider to be top doctors in their region, or nationwide. In this program, self-nominations are strictly forbidden.

A physician-led team of researchers reviews each nominee and checks the candidate's background, medical education, board certification status, hospital and educational appointments, and professional recognitions and achievements. The group also reviews malpractice and disciplinary history to further screen the candidates. The final award recipients are selected by Castle Connolly editors together with the research team.

"This award is especially significant because it is primarily driven by peer nomination," says Dr. Rohrich. "The peer-review process is an important component of reliable medical information."

A well-known advocate for patient safety, Dr. Rohrich lectures frequently around the world at surgical conferences and educational meetings promoting safe and effective as well as innovative plastic surgery practices. Dr. Rohrich serves as chairman for the Dallas Rhinoplasty Meeting and its partner conference, the Dallas Cosmetic Surgery and Medicine Meeting. He is also Editor-in-Chief of the most highly cited peer-reviewed journal in the world – "Plastic and Reconstructive Surgery", the official medical journal of the American Society of Plastic Surgeons.

"I am honored to have been selected as a Top Doctor," says Dr. Rohrich. "These types of awards are valuable tools that can help patients find well-qualified physicians within a given medical specialty all around the world. Patients should always do their research and choose their surgeon carefully. Make sure he or she is board certified by the American Board of Medical Specialties and has the expertise and the experience to deliver a safe and satisfactory outcome."

About Rod J. Rohrich, M.D., F.A.C.S.

Dr. Rod J. Rohrich is a board-certified plastic surgeon in Dallas, Texas. He is considered one of the most influential surgeons in this century. Dr. Rohrich is a Clinical Professor of Plastic Surgery at Baylor College of Medicine. He was the Founding Chair of the Department of Plastic Surgery as well as the first plastic surgeon selected as a Distinguished Teaching Professor at UT Southwestern Medical Center. He graduated from Baylor College of Medicine with high honors and completed his plastic surgery training at the University of Michigan Medical Center and fellowships at Massachusetts General Hospital/Harvard (hand/microsurgery) and Oxford University (pediatric plastic surgery). He is Chair of the Dallas Rhinoplasty Meeting, Founding Chairman of the Dallas Cosmetic Surgery and Medicine Meeting, Founding Member of the Alliance in Reconstructive Surgery, and a Founding Partner of the Dallas Plastic Surgery Institute.

He is the Editor-in-Chief of the most respected global peer-reviewed plastic surgery journal – the Journal of Plastic and Reconstructive Surgery. He developed and is Editor-in-Chief of the first open-access peer-reviewed plastic surgery journal, PRS Global Open. Dr. Rohrich has published over 900 peer-reviewed articles and six textbooks in plastic surgery

Dr. Rohrich also served as president of the American Society of Plastic Surgeons (ASPS), the largest organization of board-certified plastic surgeons in the world. He repeatedly has been selected by his peers as one of America's best doctors. He received the ASPS Special Achievement Award and on three occasions has received one of his profession's highest honors, the Plastic Surgery Educational Foundation Distinguished Service Award, which recognizes his contributions to education in plastic surgery.

Rod J. Rohrich
email us here
Rod J. Rohrich, M.D. Plastic Surgeon
+1 (214) 821-9114
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire